Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
-
Security beefed up for Ashes Test after Bondi shooting
-
Wembanyama blocking Knicks path in NBA Cup final
-
Amorim seeks clinical Man Utd after 'crazy' Bournemouth clash
-
Man Utd blow lead three times in 4-4 Bournemouth thriller
-
Stokes calls on England to 'show a bit of dog' in must-win Adelaide Test
-
Trump 'considering' push to reclassify marijuana as less dangerous
-
Chiefs coach Reid backing Mahomes recovery after knee injury
-
Trump says Ukraine deal close, Europe proposes peace force
-
French minister urges angry farmers to trust cow culls, vaccines
-
Angelina Jolie reveals mastectomy scars in Time France magazine
-
Paris Olympics, Paralympics 'net cost' drops to 2.8bn euros: think tank
-
Chile president-elect dials down right-wing rhetoric, vows unity
-
Five Rob Reiner films that rocked, romanced and riveted
-
Rob Reiner: Hollywood giant and political activist
-
Observers say Honduran election fair, but urge faster count
-
Europe proposes Ukraine peace force as Zelensky hails 'real progress' with US
-
Trump condemned for saying critical filmmaker brought on own murder
-
US military to use Trinidad airports, on Venezuela's doorstep
-
Daughter warns China not to make Jimmy Lai a 'martyr'
-
UK defence chief says 'whole nation' must meet global threats
-
Rob Reiner's death: what we know
-
Zelensky hails 'real progress' in Berlin talks with Trump envoys
-
Toulouse handed two-point deduction for salary cap breach
-
Son arrested for murder of movie director Rob Reiner and wife
-
Stock market optimism returns after tech selloff but Wall Street wobbles
-
Clarke warns Scotland fans over sky-high World Cup prices
-
In Israel, Sydney attack casts shadow over Hanukkah
-
Son arrested after Rob Reiner and wife found dead: US media
-
Athletes to stay in pop-up cabins in the woods at Winter Olympics
-
England seek their own Bradman in bid for historic Ashes comeback
-
Decades after Bosman, football's transfer war rages on
-
Ukraine hails 'real progress' in Zelensky's talks with US envoys
-
Nobel winner Machado suffered vertebra fracture leaving Venezuela
-
Stock market optimism returns after tech sell-off
-
Iran Nobel winner unwell after 'violent' arrest: supporters
-
Police suspect murder in deaths of Hollywood giant Rob Reiner and wife
-
'Angry' Louvre workers' strike shuts out thousands of tourists
-
EU faces key summit on using Russian assets for Ukraine
-
Maresca committed to Chelsea despite outburst
-
Trapped, starving and afraid in besieged Sudan city
-
Showdown looms as EU-Mercosur deal nears finish line
-
Messi mania peaks in India's pollution-hit capital
-
Wales captains Morgan and Lake sign for Gloucester
-
Serbian minister indicted over Kushner-linked hotel plan
-
Eurovision 2026 will feature 35 countries: organisers
-
Cambodia says Thailand bombs province home to Angkor temples
-
US-Ukrainian talks resume in Berlin with territorial stakes unresolved
-
Small firms join charge to boost Europe's weapon supplies
-
Driver behind Liverpool football parade 'horror' warned of long jail term
-
German shipyard, rescued by the state, gets mega deal
NYSE - LSE
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the second quarter ended October 31, 2025, on Monday, December 15, 2025, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 691139. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 53331, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Inquiries:
Gavin Cooper - Vice President, Global Marketing
[email protected]
Website: https://www.championsoncology.com/
Facebook: https://www.facebook.com/championsoncology/
LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/
Twitter: @ChampionsOncol1
Instagram: https://www.instagram.com/championsoncology/
SOURCE: Champions Oncology, Inc.
View the original press release on ACCESS Newswire
L.Durand--AMWN